Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review | Zendy

Kassem Harris | Zendy; Inga Khachaturova | Zendy; Basem Azab | Zendy; Theodore Maniatis | Zendy; Srujitha Murukutla | Zendy; Michel Chalhoub | Zendy; Hassan Hatoum | Zendy; Thomas Kilkenny | Zendy; Dany Elsayegh | Zendy; Rabih Maroun | Zendy; Homam Alkaied | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review

Author(s) -

Kassem Harris,

Inga Khachaturova,

Basem Azab,

Theodore Maniatis,

Srujitha Murukutla,

Michel Chalhoub,

Hassan Hatoum,

Thomas Kilkenny,

Dany Elsayegh,

Rabih Maroun,

Homam Alkaied

Publication year - 2012

Publication title -

clinical medicine insights oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.601

H-Index - 26

ISSN - 1179-5549

DOI - 10.4137/cmo.s9633

Subject(s) - medicine , lung cancer , presentation (obstetrics) , lymphoma , cancer , doubling time , lung , oncology , immunology , cell , pathology , cancer research , radiology , biology , genetics

Small cell lung cancer (SCLC) is one of many types rapidly growing malignant diseases, such as Burkitt's lymphoma and testicular germ cell cancers. At present, there is no reliable way to screen for SCLC, and imaging modalities tend to be delayed in detecting this type of cancer. The clinical presentation of acutely and rapidly growing SCLC can mimic those of pulmonary inflammatory or infectious disorders, and in some instances, this delays appropriate management and negatively affects patient outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research